Showing results (4111-4120 of 6,161) with videos related to

Sort By:
Pageof 617
Clinical Transplantation|February 2, 2019
Successful repair of kidney graft artery rupture secondary to infection using a preprocessed homologous "Y"-shaped iliac arteryGuangjun Liu, Xuliang Wang, Jianyong Wu, et al.
Clinical Transplantation|January 1, 2019
Prevalence, determinants, and correlates of coagulation necrosis and contraction band necrosis in donor heartsMaya Guglin, Hesham R Omar, Gregory Ray, et al.
Clinical Transplantation|January 5, 2019
Early experience with the use of hepatitis C antibody-positive, nucleic acid testing-negative donors in lung transplantationJoshua Watson, Michael S Mulvihill, Morgan L Cox, et al.
Clinical Transplantation|December 4, 2018
Severe hypertension is an independent risk factor for posterior reversible encephalopathy syndrome post-hematopoietic cell transplantation in children with thalassemia majorXin-Yu Li, Ke Huang, Dun-Hua Zhou, et al.
Clinical Transplantation|December 4, 2018
Outcomes after lung transplantation for patients with occupational lung diseasesKyla D Joubert, J Awori Hayanga, Diane C Strollo, et al.
Clinical Transplantation|March 14, 2018
Low prevalence of diabetes distress following total pancreatectomy with islet autotransplantationAudrey Lane, James S Hodges, Peggy Ptacek, et al.
Clinical Transplantation|January 29, 2019
A randomized trial comparing triiodothyronine (T3) with thyroxine (T4) for hemodynamically unstable brain-dead organ donorsRajat Dhar, Emily Stahlschmidt, Yan Yan, et al.
Clinical Transplantation|January 29, 2019
Baseline living-donor kidney volume and function associate with 1-year post-nephrectomy kidney functionIsaac E Hall, Akram Shaaban, Guo Wei, et al.
Clinical Transplantation|September 27, 2020
A retrospective cohort study exploring diltiazem as a pharmaco-enhancer for tacrolimus, in a post-heart transplant settingAbhijit R Lodha, Ashwin Pillai, Kaushik Sheth, et al.
Clinical Transplantation|September 17, 2020
Heart transplantation in patients with localized prostate cancer-Are we denying a life-saving therapy due to an indolent tumor?Jayant Raikhelkar, Michael Pham, Laura Lourenco, et al.
Pageof 617